(S (NP (NP (NNP Hepatitis) (NNP C)) (NP (NN virus) (-LRB- -LRB-) (NN HCV) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (ADJP (RB widely) (VBN spread)) (NN disease)) (PP (RB all) (IN over) (NP (DT the) (NN world))))) (. .))
(S (NP (NNP HCV)) (VP (VBZ has) (NP (NP (ADJP (RB very) (JJ high)) (NN mutation) (NN rate)) (SBAR (WHNP (WDT that)) (S (VP (VBZ makes) (S (NP (PRP it)) (ADJP (JJ resistant) (PP (IN to) (NP (NNS antibodies)))))))))) (. .))
(S (NP (NP (VBG Modeling) (NN HCV)) (SBAR (S (VP (TO to) (VP (VB identify) (NP (DT the) (NN virus) (NN mutation) (NN process))))))) (VP (VBZ is) (UCP (ADJP (JJ essential) (PP (IN to) (NP (PRP$ its) (NN detection)))) (CC and) (VP (VBG predicting) (NP (PRP$ its) (NN evolution))))) (. .))
(S (NP (DT This) (NN paper)) (VP (VBZ presents) (NP (DT a) (NN model)) (PP (VBN based) (NP (NP (NN framework)) (PP (IN for) (S (VP (VBG estimating) (NP (NP (NN mutation) (NN rate)) (PP (IN of) (NP (NNP HCV)))) (PP (IN in) (NP (CD two) (NNS steps))))))))) (. .))
(S (ADVP (RB Firstly)) (NP (NML (NML (NML (NN profile)) (VP (VBN hidden) (NP (NNP Markov) (NN model)))) (-LRB- -LRB-) (NML (NN PHMM))) (-RRB- -RRB-) (NN architecture)) (VP (VBD was) (NP (NN builder) (S (VP (TO to) (VP (VB select) (NP (NP (DT the) (NNS sequences)) (SBAR (WHNP (WDT which)) (S (VP (VBZ represents) (NP (NP (NN sequence)) (PP (IN per) (NP (NN year))))))))))))) (. .))
(S (ADVP (RB Secondly)) (NP (NN mutation) (NN rate)) (VP (VBD was) (VP (VBN calculated) (PP (IN by) (S (VP (VBG using) (NP (NP (JJ pair-wise) (NN distance) (NN method)) (PP (IN between) (NP (NNS sequences))))))))) (. .))
(S (NP (DT A) (NN pilot) (NN study)) (VP (VBZ is) (VP (VBN conducted) (PP (PP (IN on) (NP (NP (NN NS5B) (NN zone)) (PP (IN of) (NP (NNP HCV) (NN dataset))))) (PP (IN of) (NP (NN genotype) (CD 4))) (NML (NN subtype) (DT a)) (PRN (-LRB- -LRB-) (NP (NN HCV4a)) (-RRB- -RRB-))) (PP (IN in) (NP (NNP Egypt))))) (. .))
